Unknown

Dataset Information

Missed opportunities to identify cryptococcosis in COVID-19 patients: a case report and literature review.


ABSTRACT: SARS-CoV-2 may activate both innate and adaptive immune responses ultimately leading to a dysregulated immune response prompting the use of immunomodulatory therapy. Although viral pneumonia increases the risk of invasive fungal infections, it remains unclear whether SARS-CoV-2 infection, immunomodulatory therapy, or a combination of both are responsible for the increased recognition of opportunistic infections in COVID-19 patients. Cases of cryptococcosis have previously been reported following treatment with corticosteroids, interleukin (IL)-6 inhibitors, and Janus kinase (JAK) inhibitors, for patients with autoimmune diseases, but their effect on the immunologic response in patients with COVID-19 remains unknown. Herein, we present the case of a patient with COVID-19 who received high-d

SUBMITTER: Chastain DB 

PROVIDER: S-EPMC8771738 | biostudies-literature | 2022 Jan-Dec

REPOSITORIES: biostudies-literature